Working as Equals: A Biotech Plan for Big-Pharma Alliance Success

Featuring:

Nick Palmer
Partner | BTD Consulting

Carlos Keener
Managing Partner | BTD Consulting

You've heard buzz, so come learn what provoked the debate! What can small and midsized biotechs do to make themselves more attractive, and more successful partners for "big pharma?" How can they energize their alliances maintaining productive tension to drive great performance? What are the mindsets that make some smaller partners stand out in the eyes of larger firms?

This program presents the controversial findings from BTD Consulting's ongoing study and thought leadership. Combining interviews with dozens of pharmaceutical, biotech and finance senior executives with cutting-edge research, BTD is rolling out its Target of Choice whitepaper. And you are invited to be there as one of the first to learn about the findings.

This session will explore:

• Attitudes that differentiate consistent winners from also-rans
• Aggressive actions that can work, but only once
• Homework assignments where many smaller firms settle for a C-minus

Don't miss out! Learn how small and midsized biotechnology executives can position their companies for consistent alliance success. All webinar attendees will receive a copy of BTD's Target of Choice whitepaper.